Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?

Nanotechnology is revolutionizing many sectors of science, from food preservation to healthcare to energy applications. Since 1995, when the first nanomedicines started being commercialized, drug developers have relied on nanotechnology to improve the pharmacokinetic properties of bioactive molecule...

Full description

Bibliographic Details
Main Authors:	Debora B. Scariot, Austeja Staneviciute, Jennifer Zhu, Xiaomo Li, Evan A. Scott, David M. Engman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Chagas disease leishmaniasis nanotechnology drug delivery systems trypanosomatids
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.1000972/full

Similar Items

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
by: Brindha J, et al.
Published: (2021-03-01)

Editorial: New strategies for the treatment of diseases caused by trypanosomatid parasites
by: Flávia de Oliveira Cardoso, et al.
Published: (2023-06-01)

Editorial: Advances in the Molecular Biology of Trypanosomatid Pathogens: New Strategies Against Ancient Enemies
by: Gustavo Benaim, et al.
Published: (2021-10-01)

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
by: Hayelom Berhe, et al.
Published: (2024-02-01)

Investigation of the triatomine (Hemiptera: Triatominae) fauna and its infection by Trypanosoma cruzi Chagas (Kinetoplastida: Trypanosomatidae), in an area with an outbreak of Chagas disease in the Brazilian South-Western Amazon
by: Fernanda Portela Madeira, et al.
Published: (2020-09-01)

Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
by: Eliana B. Souto, et al.
Published: (2019-08-01)

Use of pharmaceutical nanotechnology for the treatment of leishmaniasis
by: Carine Santana Ferreira Marques, et al.
Published: (2019-04-01)

VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
by: Aline Maria Vasconcelos Queiroz, et al.
Published: (2021-03-01)

Occurrence of triatomines (Hemiptera, Reduviidae) and their natural infection by Trypanosoma cruzi (Chagas, 1909) in Boca do Moa community, Cruzeiro do Sul, Acre, Brazil
by: Adila Costa de Jesus, et al.
Published: (2021-03-01)

Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
by: Robin van Wijk, et al.
Published: (2021-01-01)

First report of Triatoma sordida Stål, 1859 (Hemiptera, Reduviidae, Triatominae) in the State of Acre and Brazilian Western Amazon
by: Leandro José Ramos, et al.

Polyamine Metabolism for Drug Intervention in Trypanosomatids
by: Yolanda Pérez-Pertejo, et al.
Published: (2024-01-01)

Screening of Agelasine D and Analogs for Inhibitory Activity against Pathogenic Protozoa; Identification of Hits for Visceral Leishmaniasis and Chagas Disease
by: ÃƒÂgnes ProszenyÃƒÂ¡k, et al.
Published: (2009-01-01)

Natural infection with Leishmania (Mundinia) martiniquensis supports Culicoides peregrinus (Diptera: Ceratopogonidae) as a potential vector of leishmaniasis and characterization of a Crithidia sp. isolated from the midges
by: Saowalak Kaewmee, et al.
Published: (2023-08-01)

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
by: Karine Rezende-Oliveira, et al.
Published: (2020-05-01)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
by: Roberval Nascimento Moraes Neto, et al.
Published: (2019-05-01)

Effect of chaotropes in Chagas disease and leishmaniasis cross-reacting serology assays for epidemiological surveys
by: Anderson Pacheco dos Santos, et al.

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
by: Lina S. Prieto Cárdenas, et al.
Published: (2022-05-01)

Expression and cellular localisation of Trypanosoma cruzi calpains
by: Vítor Ennes-Vidal, et al.
Published: (2020-10-01)

Evaluation of Molecular Methods to Identify Chagas Disease and Leishmaniasis in Blood Donation Candidates in Two Brazilian Centers
by: Juliana de Jesus Guimarães Ferreira, et al.
Published: (2023-03-01)

Ecos da XXII Reunião Anual de Pesquisa Aplicada em Doença de Chagas e X Reunião Anual de Pesquisa Aplicada em Leishmanioses Echoes from the 22nd Annual Applied Research Meeting on Chagas Disease and the 10th Annual Applied Research Meeting on Leishmaniasis
by: Luiz Fernando Junqueira Junior
Published: (2006-12-01)

Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease
by: Catherine W. Cai, et al.
Published: (2022-11-01)

Patrones diferenciales entre Leishmaniasis y chagas, empleando epimastigotes de trypanosoma cruzi
by: N. Marisol Córdova R, et al.
Published: (2020-12-01)

Amplicon-based next-generation sequencing reveals the co-existence of multiple Leishmania species in patients with visceral leishmaniasis
by: Adriana Castillo-Castañeda, et al.
Published: (2022-02-01)

Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis
by: Vítor Ennes-Vidal, et al.

Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
by: Greta Volpedo, et al.
Published: (2019-02-01)

Application of Liposome Technology in the Treatment of Leishmaniasis: Past, Present and Future
by: Amir Mellati, et al.
Published: (2023-12-01)

Nano-Medicines a Hope for Chagas Disease!
by: Satabdi Datta Choudhury
Published: (2021-06-01)

Neglected tropical diseases in Brazilian children and adolescents: data analysis from 2009 to 2013
by: Eduardo Brandão, et al.
Published: (2017-11-01)

Nano Based Approach for the Treatment of Neglected Tropical Diseases
by: Sureshbabu Ram Kumar Pandian, et al.
Published: (2021-06-01)

Vaccination with Formulation of Nanoparticles Loaded with <i>Leishmania amazonensis</i> Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster
by: Marco Antonio Cabrera González, et al.
Published: (2023-01-01)

Patrones de coloración en la inmunofluorescencia indirecta y su utilidad en el diagnóstico de leishmaniasis tegumentaria y enfermedad de Chagas
by: Luis Vásquez Huerta, et al.
Published: (2011-03-01)

Natural Products and Synthetic Derivatives as Promising Candidates Against Neglected Tropical Diseases
by: Ana Flávia dos Santos Fuzaro, et al.
Published: (2022-12-01)

Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites
by: Sanjay Varikuti, et al.
Published: (2018-11-01)

Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe
by: Jean-Claude Dujardin, et al.
Published: (2008-07-01)

Potential of Triterpenic Natural Compound Betulinic Acid for Neglected Tropical Diseases New Treatments
by: Vinícius Rocha, et al.
Published: (2022-04-01)

Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases
by: T. Déirdre Hollingsworth, et al.
Published: (2015-12-01)

Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America
by: Eloan Pinheiro, et al.

Serodiagnosis of visceral and cutaneous leishmaniasis in human and canine populations living in Indigenous Reserves in the Brazilian Amazon Region
by: Julia Teresa Ribeiro de Lima, et al.

SCRUTINIZING THE BIOMARKERS FOR THE NEGLECTED CHAGAS DISEASE: HOW REMARKABLE!
by: Rosa Pinho, et al.
Published: (2016-08-01)